As per the Governor's shut down we are working remotely, however rest assured that we are still working to protect your rights! Please email us at for Dina Brilliant and for Glenn Neiman or call us at (215) 638-7500 and leave a message as we are checking our messages.

A new Frequently Asked Question has been, "I have the Coronavirus, can I get workers' compensation benefits?" The answer is that, yes, you may be entitled to workers compensation benefits depending on the facts. This can be whether you have contracted COVID-19 through work, or whether you have lost a modified duty job through an employer closing or layoff. Email or call us to discuss the specifics of your case in regard to the Coronavirus or any other work injury.

Knee Injuries May Have New Treatment in Future

Recently, two pharmaceutical companies, Genzyme Corporation and Osiris Therapeutics,
announced that they have joined to develop two adult stem cell treatments. These medications, known as Prochymal and Chondrogen, may be a valuable resource to treat a wide variety of conditions. Benefits from these treatments may include control of inflammation, development of tissue regeneration and prevention of scar formation.

Clinical trials for Prochymal are currently underway for Crohn’s disease, diabetes, chronic obstructive pulmonary disease (COPD) and acute myocardial infarction. Chondrogen, to interest of those injured workers suffering from persistent knee pain, is in clinical trials to treat osteoarthritis of the knee.

Genzyme is no stranger to development of treatments for knee injuries. In fact, the company developed and commercialized the first-ever cell therapy product approved by the FDA, Carticel, used in knee cartilage repair. Genzyme’s products also include Synvisc, used to address the pain associated with osteoarthritis of the knee. The hope is that Chondrogen can not only treat the osteoarthritic knee pain, but also may be able to actually cure the disease.

Contact Information